The interaction between atrial fibrillation and mitral regurgitation: Insights from the CABANA randomized clinical trial.

Eur J Heart Fail · 2025 · PMC12482842 · PMID 40256860

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

showed a trendp = 0.072so close (0.05 < p ≤ 0.1)

Notably, patients with ≥ moderate MR showed a trend toward increased all‐cause mortality, regardless of the treatment randomization (HR 1.9, 95% CI 0.95–3.64, p = 0.072).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.